Home News Drug Discovery & Development

Drug Discovery & Development

Cadila Healthcare divests its entire stake in Bremer Pharma, Germany

Mumbai, April 20, 2018: Cadila Healthcare said that company has divested its entire shareholding in Bremer Pharma GmbH, Germany (Bremer), a wholly owned subsidiary of the company and consequently, Bremer ceased to be a subsidiary of the company. The company received...

New potential breast cancer drug identified

New Delhi, April 20,  2018: Scientists, including an Indian-American researcher, have identified a molecule that can help treat breast cancer, giving hope to patients who have become resistant to traditional therapies. The first-in-class molecule shuts down oestrogen-sensitive breast cancer in...

Nifty Pharma index in the red; Cipla, Lupin top drags 

New Delhi, November 27, 2017: Pharma stocks CiplaBSE -0.46 % (down 1.70 per cent), GlaxoSmithKline PharmaceuticalsBSE -0.79 % (down 0.92 per cent) and LupinBSE 0.30 % (down 0.42 per cent) were trading down in afternoon trade on Monday, dragging the...

Cipla inks third respiratory deal in less than a week

In pact with Biopharm to set up company in Algeria Mumbai, Feb 17, 2015 : Drugmaker Cipla has inked its third deal in less than a week, all aimed at beefing up its capacity in the respiratory products segment. On Friday, Cipla...

Decontrolling drug prices: SC refuses to interfere

New Delhi, October 2014 - The Supreme Court on Monday refused to interfere with the Centre's decision to decontrol prices of 108 cardiac and diabetes drugs saying the issue can be raised before the competent authority through representation. "You approach...

Venus Remedies ties up with Israel’s Teva for anti-cancer drug

Chandigarh, August 27, 2014 -  Pharma major Venus Remedies today said it has entered into a collaborative agreement with Israel-based generic drug maker Teva for selling an anti- cancer drug in the Canadian market. Under this collaboration, Venus Remedies will be initially manufacturing the...

Venus Remedies gets Swiss nod to market oncology drug

Chandigarh, august 21, 2014 - Pharma major Venus Remedies has secured its first marketing authorisation in Switzerland from Swiss drug authority ‘Swissmedic’ for its oncology drug ’Gemcitabine’ The marketing approval for Gemcitabine will help the company further strengthen its oncology...

Glenmark study on novel antibody

MUMBAI, AUGUST 21, 2014: Drugmaker Glenmark Pharmaceuticals is set to initiate studies on its novel drug candidate, GBR 1302, an antibody with dual specificities. Explaining the significance of the discovery, Michael Buschle, Glenmark’s Chief Scientific Officer and President (Biologics) said...

Cipla bets big on cell therapy

Mumbai , March 22,2014 - Stem cells are set to be a major branch of medical treatment, says Cipla Chairman YK Hamied. Regenerative medicine, or cell therapy, is a rapidly emerging area of biomedical research and would be...

AstraZeneca to shut R&D centre in Bangalore

168 research jobs at stake; had during 2012 shed some R&D jobsBangalore January 31, 2014: AstraZeneca, the global pharmaceutical major,  said that it will close its research and development site in Bangalore later this year.  The ‘Avishkar R&D Site’,...